BRINK'S RECEIVES CMA ACCEPTANCE IN PRINCIPLE OF PROPOSED REMEDY RELATING TO PENDING ACQUISITION OF NCR ATLEOS
BRINKS CO (BCO) filed an SEC Form 8-K — Other Events. Exhibit 99.1 P R E S S R E L E A S E Contact: Investor Relations 804.289.9709 BRINK’S CORPORATE The Brink’s Company 1801 Bayberry Court Richmond, VA 23226-8100 USA BRINK'S RECEIVES CMA ACCEPTANCE IN PRINCIPLE OF PROPOSED REMEDY RELATING TO PENDING ACQUISITION OF NCR ATLEOS Divest
How this was made
The 30-second read
Why it matters
Regulatory clearance reduces deal uncertainty, likely supporting both Brink's and NCR Atleos share prices.
Market read
The acceptance clears a major regulatory hurdle, making the acquisition more likely to close as scheduled.
What to watch
Potential antitrust concerns in other jurisdictions and integration risks remain.
Background
Brink's announced that the UK Competition and Markets Authority has accepted in principle its proposed remedy for the pending acquisition of NCR Atleos, allowing the divestiture of NoteMachine/TestLink UK to avoid a Phase 2 referral.
Ticker impact
CMA accepted Brink's proposed remedy, clearing a key regulatory hurdle for its pending acquisition of NCR Atleos.
likely upward pressure as the market prices in reduced regulatory risk
The acceptance in principle removes a potential Phase 2 referral, a material obstacle for the transaction.
The CMA acceptance pertains to Brink's acquisition of NCR Atleos, keeping the transaction on track for early 2027 close.
potential modest upside as investors view the deal as less risky
Regulatory clearance for the buyer improves the likelihood of deal closure, supporting the target's valuation.
Market effects
The cash handling and security services sector may see increased M&A activity confidence.
UK regulatory clearance may ease similar cross‑border deals in Europe.
The transaction is a notable M&A move in the global financial services space.
Counterpoint
If the CMA later imposes stricter conditions, the deal could face delays, pressuring both stocks.
Key entities
- CompanyThe Brink's Company
US‑listed cash and valuables management firm (ticker BCO).
- CompanyNCR Atleos Corporation
US‑listed provider of ATM and retail solutions (ticker NATL).
- RegulatorUK Competition and Markets Authority
UK competition regulator that approved the remedy.
